Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
Authors
Keywords
MicroRNAs, Cancer treatment, Colorectal cancer, Biomarkers, Angiogenesis, Colon, Cancer chemotherapy, In situ hybridization
Journal
PLoS One
Volume 9, Issue 10, Pages e109430
Publisher
Public Library of Science (PLoS)
Online
2014-10-21
DOI
10.1371/journal.pone.0109430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
- (2013) M. K. Boisen et al. ANNALS OF ONCOLOGY
- Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway
- (2013) K. Nosho et al. CARCINOGENESIS
- Markers of Response for the Antiangiogenic Agent Bevacizumab
- (2013) Diether Lambrechts et al. JOURNAL OF CLINICAL ONCOLOGY
- DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
- (2013) Maria D. Paraskevopoulou et al. NUCLEIC ACIDS RESEARCH
- Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials
- (2013) H. I. Hurwitz et al. ONCOLOGIST
- Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
- (2013) Kristina Schee et al. PLoS One
- The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review
- (2013) Haggi Mazeh et al. Journal of Cancer
- The Synaptic Proteins β-Neurexin and Neuroligin Synergize With Extracellular Matrix-Binding Vascular Endothelial Growth Factor A During Zebrafish Vascular Development
- (2012) Alberto Rissone et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
- (2012) Douglas G Altman et al. BMC Medicine
- Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters
- (2012) N. Nishida et al. CLINICAL CANCER RESEARCH
- microRNAs in cancer management
- (2012) Yi W Kong et al. LANCET ONCOLOGY
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development
- (2012) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
- (2012) Marek Svoboda et al. Radiation Oncology
- MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
- (2012) Neda Mosakhani et al. Cancer Genetics
- Neurexins and neuroligins: synapses look out of the nervous system
- (2011) Alessia Bottos et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
- (2010) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- MicroRNAs in cancer: personalizing diagnosis and therapy
- (2010) S. Patrick Nana-Sinkam et al. Annals of the New York Academy of Sciences
- High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
- (2010) Boye Schnack Nielsen et al. CLINICAL & EXPERIMENTAL METASTASIS
- miRNAs in human cancer
- (2010) Thalia A Farazi et al. JOURNAL OF PATHOLOGY
- Biomarkers to predict the clinical efficacy of bevacizumab in cancer
- (2010) Adrian M Jubb et al. LANCET ONCOLOGY
- A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer
- (2009) C. Qvortrup et al. ANNALS OF ONCOLOGY
- Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states
- (2009) Aaron L Sarver et al. BMC CANCER
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions
- (2009) A. Bottos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search